OWC Pharmaceutical Research Corp. Stock
Equities
OWCP
US67109N1081
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | 0.00% |
2021 | OWC Pharmaceutical Research Corp. Announces Resignation of David Kugelman as the Sole Director | CI |
2021 | Discover Growth Enters into Agreement with OWC Pharmaceutical | CI |
Financials (USD)
Sales 2017 | - | Sales 2018 | - | Capitalization | 15.37M |
---|---|---|---|---|---|
Net income 2017 | -4M | Net income 2018 | -10M | EV / Sales 2017 | - |
Net cash position 2017 | 971K | Net cash position 2018 | 3.46M | EV / Sales 2018 | - |
P/E ratio 2017 |
-14.5
x | P/E ratio 2018 |
-1.21
x | Employees | 9 |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Ziv Turner
CEO | Chief Executive Officer | 52 | 20-06-20 |
Shmuel De-Saban
DFI | Director of Finance/CFO | 57 | 14-06-15 |
Yehuda Baruch
CTO | Chief Tech/Sci/R&D Officer | 67 | 16-11-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Shmuel De-Saban
DFI | Director of Finance/CFO | 57 | 20-06-24 |
Ziv Turner
CEO | Chief Executive Officer | 52 | 20-06-20 |
Hannah Fayer
BRD | Director/Board Member | 69 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 0.000001 | 0.00% | 30,000 |
Delayed Quote OTC Markets, April 29, 2024 at 02:09 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
0.00% | 497 | |
-13.60% | 19.22B | |
-46.59% | 2.63B | |
+17.50% | 1.86B | |
-0.58% | 1.66B | |
+26.25% | 1.23B | |
-8.67% | 1.05B | |
-21.91% | 894M | |
-3.09% | 740M | |
-17.51% | 687M |
- Stock Market
- Equities
- OWCP Stock